Teva comes out on top with $5B Ratiopharm bid
And the winner is… Teva. This morning, the generics giant announced that it was buying Ratiopharm for just under $5 billion, beating out Pfizer and Actavis for the German company.
March 18th, 2010 | Health News Category : Pharma
And the winner is… Teva. This morning, the generics giant announced that it was buying Ratiopharm for just under $5 billion, beating out Pfizer and Actavis for the German company.
About - Contact - Privacy Policy - Sitemap - Copyright © VitaminsHealth.Net Theme by Jakarta Freelancer - proudly powered by WordPress